Clinical Outcome and Molecular Analysis of a Chinese Patient With Lung Adenocarcinoma Harboring Rare EGFR Mutation V834L

J Thorac Oncol. 2018 Oct;13(10):e189-e191. doi: 10.1016/j.jtho.2018.04.021. Epub 2018 Apr 27.

Authors

Juan Li¹, Lei Zhang², Yan Wu³, Wanning Yang², Zhenzhou Yang³, Henghui Zhang⁴

Affiliations

¹ Cancer Center, Daping Hospital and Research Institute of Surgery, Third Military Medical University, Chongqing, China.
² Genecast Precision Medicine Technology Institute, Beijing, China.
³ Cancer Center, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, China.
⁴ Institute of Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing, China. Electronic address: zhhbao@ccmu.edu.cn.

PMID: 29705137
DOI: 10.1016/j.jtho.2018.04.021

No abstract available

Publication types

Case Reports

MeSH terms

Adenocarcinoma of Lung / genetics*
Adenocarcinoma of Lung / pathology
Adolescent
Asian People
ErbB Receptors / genetics
Female
Humans
Mutation

Substances

EGFR protein, human
ErbB Receptors